AIM IMMUNOTECH INC: Diferență între versiuni
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei AIM IMMUNOTECH INC listata cu simbolul US.AIM ==Descriere companie== AIM ImmunoTech Inc. (aimimmuno.com) is a specialty pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. The Company's products are Alferon N Injection and Ampligen. Alferon N Injection is a natural-source, glycosylated, multi-species alpha interferon produc...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
AIM ImmunoTech Inc. (aimimmuno.com) is a specialty pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. The Company's products are Alferon N Injection and Ampligen. Alferon N Injection is a natural-source, glycosylated, multi-species alpha interferon product. Alferon is used for the treatment of refractory (resistant to other treatment) or recurring external genital warts in patients 18 years of age or older. Ampligen (rintatolimod), which is a drug of macromolecular RNA (ribonucleic acid) molecules, it is a sterile solution indicated for the treatment of severely debilitated patients with Chronic Fatigue Syndrome (CFS) who have been diagnosed for longer than one year. Ampligen is used in combination with checkpoint blockade therapies. Ampligen is also being used as a monotherapy to treat pancreatic cancer patients. | AIM ImmunoTech Inc. (aimimmuno.com) is a specialty pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. The Company's products are Alferon N Injection and Ampligen. Alferon N Injection is a natural-source, glycosylated, multi-species alpha interferon product. Alferon is used for the treatment of refractory (resistant to other treatment) or recurring external genital warts in patients 18 years of age or older. Ampligen (rintatolimod), which is a drug of macromolecular RNA (ribonucleic acid) molecules, it is a sterile solution indicated for the treatment of severely debilitated patients with Chronic Fatigue Syndrome (CFS) who have been diagnosed for longer than [[one]] year. Ampligen is used in combination with checkpoint blockade therapies. Ampligen is also being used as a monotherapy to treat pancreatic cancer patients. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||
Versiunea curentă din 29 septembrie 2024 03:42
Pagina dedicata companiei AIM IMMUNOTECH INC listata cu simbolul US.AIM
Descriere companie[edit | ]
AIM ImmunoTech Inc. (aimimmuno.com) is a specialty pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. The Company's products are Alferon N Injection and Ampligen. Alferon N Injection is a natural-source, glycosylated, multi-species alpha interferon product. Alferon is used for the treatment of refractory (resistant to other treatment) or recurring external genital warts in patients 18 years of age or older. Ampligen (rintatolimod), which is a drug of macromolecular RNA (ribonucleic acid) molecules, it is a sterile solution indicated for the treatment of severely debilitated patients with Chronic Fatigue Syndrome (CFS) who have been diagnosed for longer than one year. Ampligen is used in combination with checkpoint blockade therapies. Ampligen is also being used as a monotherapy to treat pancreatic cancer patients.
Grafic actiuni companie[edit | ]